Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.

Saved in:
Bibliographic Details
Title: Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.
Authors: Perutelli F; University Division of Hematology, A.O.U. Città Della Salute e Della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Boccellato E; Azienda Santa Croce e Carle, Cuneo, Italy., Montalbano MC; University Division of Hematology, A.O.U. Città Della Salute e Della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Catania G; Dipartimento di Medicina Traslazionale Università del Piemonte Orientale and S.C.D.U, Ematologia Azienda Ospedaliero Universitaria Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Deodato M; Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Frustaci AM; Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Innocenti I; Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Moia R; Division of Hematology, Azienda Ospedaliero-Universitaria Maggiore Della Carità, Novara, Italy., Quaglia FM; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Quaresmini G; Department of Oncology and Hematology University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy., Rivela P; Dipartimento di Medicina Traslazionale Università del Piemonte Orientale and S.C.D.U, Ematologia Azienda Ospedaliero Universitaria Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Gaidano G; Division of Hematology, Azienda Ospedaliero-Universitaria Maggiore Della Carità, Novara, Italy., Krampera M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Laurenti L; Department of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, Italy., Rambaldi A; Department of Oncology and Hematology University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy., Bruno B; University Division of Hematology, A.O.U. Città Della Salute e Della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Vitale C; University Division of Hematology, A.O.U. Città Della Salute e Della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Coscia M; Department of Medicine and Surgery, University of Insubria, Varese, Italy.; Department of Oncology, ASST Sette Laghi, Varese, Italy.
Source: British journal of haematology [Br J Haematol] 2025 Mar; Vol. 206 (3), pp. 924-929. Date of Electronic Publication: 2025 Jan 07.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.19976